Unlock instant, AI-driven research and patent intelligence for your innovation.

HIV-1 latent infection activator thiostreptavidin

A technology of thiostrepton and HIV-1, applied in the field of HIV-1 latent infection activator thiostrepton, can solve the problems of incomplete reactivation, cytokine storm, life-threatening, etc., and achieve good promotion and application Value, less cytotoxic side effects

Active Publication Date: 2020-04-07
SUN YAT SEN UNIV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Suboptimal efficacy of activators of latent infection or acting on a single mechanism can result in incomplete reactivation due to multiple molecular mechanisms maintaining latent reservoirs of HIV-1
Additionally, PKC agonists have been shown to effectively induce HIV-1 activation in vivo and in vitro, but can cause global activation of T cells, cytokine storm, and life-threatening inflammatory responses due to non-specific induction
Another latent infection activator, SAHA, impairs HIV-1-specific cytotoxic lymphocyte function and was shown to fail to reduce HIV-1 latent reservoirs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • HIV-1 latent infection activator thiostreptavidin
  • HIV-1 latent infection activator thiostreptavidin
  • HIV-1 latent infection activator thiostreptavidin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1 Construction of HIV-1 Primary Cell Latent Infection Model

[0033] 1. Transduction and amplification of Bcl-2

[0034] Firstly, CD4+ T cells in normal human PBMCs were screened out with magnetic beads. After activation of Anti-CD3 / 28 and IL-2, they were infected with lentivirus EB-FLV carrying the anti-apoptotic gene Bcl-2. In the absence of TCR stimulation and exogenous After cultured for 3-4 weeks in the presence of sex cytokines, dead cells were removed by Ficoll density gradient centrifugation to obtain primary CD4+ T cell lines that could stably express Bcl-2.

[0035] (1) Experimental method

[0036] 1. Isolate PBMC from healthy donors, and obtain CD4+ T cells by BD negative selection magnetic beads, resuspend in STCM, and the cell density is 1×10 6 / ml for activation in 6-well plates.

[0037] 2. Collect activated CD4+ T cells, take an appropriate amount of cells after centrifugation, take an appropriate amount of cells after centrifugation, and resu...

Embodiment 2

[0070] Activation of embodiment 2 thiostrepton to latent HIV-1

[0071] 1. Experimental method

[0072] The sorted GFP-negative cells were stimulated and activated by flow cytometry, and the expression of GFP in cells was detected by flow cytometry. The negative control is DMSO, the positive control is PMA / Ionomycin, and the reported latent activators such as panobinostat, bryostatin, disulfiram, JQ1 are used for control.

[0073] 2. Experimental results

[0074] Typically, reactivation of GFP-negative cells in this model induces GFP fluorescence in 1% to 6% of cells. After ensuring that the GFP positive rate of reactivated cells in the PMA / Ionomycin group reached at least 1%, the activation effect of the small molecule compound thiostrepton on latent HIV-1 was detected.

[0075] The results showed that the effect of thiostrepton was stronger than that of other known activator controls, even higher than that of the PMA / Ionomycin group ( image 3 ).

Embodiment 3

[0076] The screening of embodiment 3 thiostrepton optimum action concentration

[0077] 1. Experimental method

[0078] In order to determine the optimal concentration of thiostrepton, different drug concentrations were set up for activation experiments, including 7 groups of 100nM, 250nM, 500nM, 1μM, 2.5μM, 5μM and 10μM, and the diluent DMSO treatment group was used as Negative control, PHA as positive control. The duration of action is 3 days.

[0079] 2. Experimental results

[0080] The results showed that as the dosage of thiostrepton increased, the activation efficiency increased gradually, and the reactivation ratio reached the maximum at 1 μM, and the activation effect of donor1 was even higher than that of the positive control group at the concentration of 1 μM. Afterwards, with the increase of drug concentration, the activation rate began to decrease gradually ( Figure 4 ). This result indicates that the optimal action concentration of thiostrepton is 1 μM, and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an HIV-1 latent infection activator thiostreptavidin. According to the invention, the thiostreptavidin and / or pharmaceutically acceptable salt thereof are / is used as an HIV-1 latent infection activator. The invention provides a novel small molecular compound, namely Thiostrepton. The compound can effectively activate latent HIV-1 infected cells, has small toxic and side effects on cells, does not cause activation of global T cells, is expected to be developed into a novel latent sensation activator in the future and enter clinical tests, and has good popularization andapplication values.

Description

technical field [0001] The invention relates to the technical field of prevention and treatment of HIV virus, and more specifically relates to an HIV-1 latent infection activator thiostrepton. Background technique [0002] The human immunodeficiency virus (Human Immunodeficiency Virus, HIV) was discovered in 1981, and later proved to be able to cause acquired immunodeficiency syndrome (acquired immunodeficiency syndrome, AIDs), which is a very harmful to humans Retroviral. After HIV enters the body, it mainly attacks the CD4 lymphocytes of the human immune system, causing a sharp decrease in the number of CD4 cells in the body, a large number of immune cells are destroyed, and the immune system of the body collapses, which leads to a high incidence of various opportunistic infections and cancers, eventually causing Death of an infected patient. [0003] The advent of combined antiretroviral therapy (cART) effectively controls the HIV-1 virus and represents a milestone in m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/12A61P31/18
CPCA61K38/12A61P31/18
Inventor 邓凯彭雯
Owner SUN YAT SEN UNIV